Position in LLY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$705,782,748
+$13,684,467 QoQ
Shares Held
767,347
+19.2% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.85%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026SEI INVESTMENTS CO holds $2,568,983,951 across 16 Drug Manufacturers - General names. LLY ranks #1 (27.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
767,347 | $705,782,748 | |
| 2 | JNJ |
Johnson & Johnson
|
1,961,422 | $479,449,993 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,102,456 | $252,904,431 | |
| 4 | ABBV |
AbbVie Inc.
|
884,601 | $192,391,870 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,158,099 | $161,404,257 | |
| 6 | AZN |
Astrazeneca PLC
|
683,752 | $134,849,568 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,199,004 | $133,369,592 | |
| 8 | GSK |
GSK plc
|
2,286,880 | $126,212,906 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $705,782,748 | 767,347 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $692,098,281 | 644,004 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $429,069,235 | 562,345 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $521,764,372 | 669,332 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $558,562,932 | 676,300 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $409,352,228 | 530,249 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $485,449,049 | 547,948 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $442,901,935 | 489,189 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $362,138,045 | 465,497 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $271,806,269 | 466,284 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $254,307,957 | 473,457 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $204,773,550 | 436,636 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $121,551,791 | 353,945 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $108,308,394 | 296,054 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $116,570,907 | 360,510 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $115,437,226 | 356,035 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $95,934,235 | 335,001 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $88,835,665 | 321,612 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $70,767,378 | 306,286 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $69,646,465 | 303,444 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $61,608,377 | 329,774 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $85,646,114 | 507,262 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $74,228,179 | 501,474 | Shares | Defined | 2020-12-04 | |
| 2020-06-30 | $94,850,725 | 577,724 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $72,506,584 | 522,683 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||